Professor Shahina Pardhan to lead new vision research unit


Professor Shahina Pardhan has been appointed director of Anglia Ruskin University's new Vision and Eye Research Unit (VERU).

Professor Shahina Pardhan has been appointed director of Anglia Ruskin University’s new Vision and Eye Research Unit (VERU).

Professor Pardhan has an extensive background in optometry and research based on the clinical assessment of visual functions in range of normal and abnormal ocular conditions including myopia, low vision and normal vision. She was the first woman to become Professor of Optometry at Anglia Ruskin University and has been awarded the Asian Jewel Award (Health care and education category) and the Asian Women of Achievement award.

Talking to the Cambridge Network she said: "I am really looking forward to this exciting new venture and working with vision and eye researchers both within Anglia Ruskin and externally. We have an outstanding team here, offering world-leading expertise which is already proving attractive to organisations seeking to fulfil their research and development needs."

VERU will build on existing collaborations and build new research partnerships both in- and outside the university, including the NHS and partners in the optical and pharmaceutical industries. Other experts involved with the unit include Professor Rupert Bourne, Professor of Ophthalmology at Anglia Ruskin, Professor Roger Buckley, Professor of Ocular Medicine at Anglia Ruskin and Dr Sarah Waugh, Reader in the Department of Optometry and Ophthalmic dispensing at Anglia Ruskin.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.